<DOC>
	<DOC>NCT00185146</DOC>
	<brief_summary>The effect of pactimibe on the reduction of atherosclerosis in the carotid artery will be assessed using carotid ultrasound</brief_summary>
	<brief_title>Efficacy and Safety of Pactimibe in Patients With Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Increased cardiovascular risk (i.e. history of myocardial infarction, stroke, diabetes mellitus, left ventricular hypertrophy) Intimamedia thickness greater than or equal to 0.8 mm as measured by ultrasonography Negative pregnancy test for females Whole blood donation (greater than or equal to 450 ml) during the last three months before study start Unstable angina, congestive heart failure or uncontrolled hypertension Renal disease including nephrectomy and/or renal transplant Hepatic disease or abnormal liver function parameters Drug abuse or alcohol addiction</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>